[ad_1]
They were discontinued due to illness in one of the volunteers
The pharmaceutical company AstraZeneca and the University of Oxford resumed clinical trials of a coronavirus vaccine after testing was stopped due to illness in one of the volunteers, the company said, cited by BGNES.
Why were trials of the Oxford coronavirus vaccine stopped?
“Clinical trials of the AZD1222 vaccine have resumed in the UK after receiving confirmation from the Medicines and Healthcare Products Authority (MHRA) that it is safe to continue trials,” the University of Oxford said in a statement.
AstraZeneca and the University did not release details about the sick volunteer’s medical diagnosis.
We remind you that on September 6 the tests of the vaccine were stopped in all countries of the world to be able to independently investigate the disease of the volunteer in whom it was tested.
Oxford coronavirus vaccine stopped
Company representatives did not specify what happened to the volunteer and how much it would affect the subsequent course of clinical trials. A New York Times source claims that it is transverse (transverse) myelitis, an acute inflammation of the spinal cord that sometimes occurs in viral infections.
After examining the situation and the medical history of the patient, British scientists have concluded that the tests can continue safely.
The second possible Russian vaccine produced no side effects in the trials.
The day before, the head of the company Pascal Sorio said that AstraZeneca hopes to know before the end of the year if the vaccine it is developing protects against the coronavirus.
Subscribe FREE to the nova.bg newsletter HEREto receive the most important news of the day in your email.
[ad_2]
